Amneal Pharmaceuticals
AMRX
#2937
Rank
โ‚น553.98 B
Marketcap
โ‚น1,735
Share price
0.95%
Change (1 day)
144.70%
Change (1 year)

Revenue for Amneal Pharmaceuticals (AMRX)

Revenue in 2026 (TTM): โ‚น272.44 Billion

According to Amneal Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น292.09 Billion. In 2025 the company made a revenue of โ‚น270.99 Billion an increase over the revenue in the year 2024 that were of โ‚น239.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amneal Pharmaceuticals from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น272.44 B0.54%
2025 โ‚น270.99 B13.06%
2024 โ‚น239.68 B20.28%
2023 โ‚น199.26 B8.85%
2022 โ‚น183.06 B17.48%
2021 โ‚น155.83 B6.94%
2020 โ‚น145.72 B25.65%
2019 โ‚น115.97 B-0.26%
2018 โ‚น116.28 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น55.72 B-80.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.67 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA